1-20 of 1,606 results for askedby:"David Linden"
Librarians' tools
- Search time
- 0.33 seconds
- Solr query time
- 0.006 seconds
- Search query
- askedby:"David Linden"
- We searched for
- tablingMember_ses:437190 OR askingMember_ses:437190
Type
House
Session
Year
Department
More
Member
More
Primary member
Answering member
More
Legislative stage
Legislation
Subject
More
Publisher
The Secretary of State is right to say that “in due course” is on people’s lips, because the reality is that 270,000 WASPI women have now died, as they do with every passing day. Indeed, nine WASPI
women would have died in the time our Select Committee hearing took on Tuesday. Is not the issue here that the Government hope that this issue will be lost during the course of an election campaign, and that the two big parties can concoct a situation in which we ignore the matter, more women will die, and more 1950s women will be denied the justice that they deserve?
The Secretary of State is right to say that “in due course” is on people’s lips, because the reality is that 270,000 WASPI women have now died, as they do with every passing day. Indeed, nine WASPI
women would have died in the time our Select Committee hearing took on Tuesday. Is not the issue here that the Government hope that this issue will be lost during the course of an election campaign, and that the two big parties can concoct a situation in which we ignore the matter, more women will die, and more 1950s women will be denied the justice that they deserve?
I simply do not accept that that is a fair assessment of the very considerable time and effort that we are putting into taking this matter extremely seriously.
In evidence to the Work and Pensions Committee on Tuesday, the ombudsman essentially said that the reason it decided to lay the report before Parliament was that it could not trust the Government to deal with it. I ask the Secretary of State a simple question: does he have confidence in the ombudsman, and does he accept its report?
In evidence to the Work and Pensions Committee on Tuesday, the ombudsman essentially said that the reason it decided to lay the report before Parliament was that it could not trust the Government to deal with it. I ask the Secretary of State a simple question: does he have confidence in the ombudsman, and does he accept its report?
I have made our position extremely clear: we are considering the report and it will come back to the House in due course and without undue delay. The ombudsman has, as the hon. Gentleman indicated, invited the House to express its opinion as well. That is something that we will consider alongside the matters raised in the report.
To ask the Secretary of State for Environment, Food and Rural Affairs, when his Department plans to respond to email correspondence of (a) 11 January, (b) 8 February, (c) 1 March and (d) 15 March 2024 from the hon. Member for Glasgow East with references (i) MC2024/00868 and (ii) DL17224.
To ask the Secretary of State for Environment, Food and Rural Affairs, when his Department plans to respond to email correspondence of (a) 11 January, (b) 8 February, (c) 1 March and (d) 15 March 2024 from the hon. Member for Glasgow East with references (i) MC2024/00868 and (ii) DL17224.
A response to the hon. Member was sent out on 30 April 2024. I apologise to the hon. Member for the delay in responding.
To ask the Secretary of State for Work and Pensions, with reference to the press release entitled Disability benefits system to be reviewed as PM outlines "moral mission" to reform welfare, published on 19 April 2024, what discussions he has had with the Scottish Government on the recently announced proposed...
To ask the Secretary of State for Work and Pensions, with reference to the press release entitled Disability benefits system to be reviewed as PM outlines "moral mission" to reform welfare, published on 19 April 2024, what discussions he has had with the Scottish Government on the recently announced proposed...
The department discusses various aspects of social security with the Scottish Government, at both Ministerial and official level. We continue to engage with the Scottish Government to consider the implications of the proposals outlined in the Prime Minister’s announcement and the Health and Disability Green Paper consultation in Scotland.
Modernising Support for Independent Living: The Health and Disability Green Paper was published on Monday 29 April.
The UK Government is committed to improving the lives of disabled people and people with long-term health conditions in all parts of the UK. Personal Independence Payment (PIP) is devolved in Scotland and has been replaced with Adult Disability Payment. No new claims to PIP have been made in Scotland since August 2022.
However, DWP continues to deliver PIP in Scotland for existing cases on behalf of Scottish Ministers whilst Scottish cases are being transferred to Social Security Scotland. All cases are due to be transferred in 2025 and DWP will no longer have any delegated administrative authority regarding PIP in Scotland once transfer is complete.
To ask the Secretary of State for Work and Pensions, what discussions he has had with the Scottish Government on the upcoming consultation on the Personal Independence Payment reforms.
To ask the Secretary of State for Work and Pensions, what discussions he has had with the Scottish Government on the upcoming consultation on the Personal Independence Payment reforms.
The department discusses various aspects of social security with the Scottish Government, at both Ministerial and official level. We continue to engage with the Scottish Government to consider the implications of the proposals outlined in the Prime Minister’s announcement and the Health and Disability Green Paper consultation in Scotland.
Modernising Support for Independent Living: The Health and Disability Green Paper was published on Monday 29 April.
The UK Government is committed to improving the lives of disabled people and people with long-term health conditions in all parts of the UK. Personal Independence Payment (PIP) is devolved in Scotland and has been replaced with Adult Disability Payment. No new claims to PIP have been made in Scotland since August 2022.
However, DWP continues to deliver PIP in Scotland for existing cases on behalf of Scottish Ministers whilst Scottish cases are being transferred to Social Security Scotland. All cases are due to be transferred in 2025 and DWP will no longer have any delegated administrative authority regarding PIP in Scotland once transfer is complete.
To ask the Secretary of State for Work and Pensions, what steps his Department takes to ensure that single household payments of Universal Credit are paid into the main caregiver’s account.
To ask the Secretary of State for Work and Pensions, what steps his Department takes to ensure that single household payments of Universal Credit are paid into the main caregiver’s account.
A prompt on the online Universal Credit application form, suggests that the customer uses the bank, building society or credit union account details for the carer who spends the most time looking after the children.
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential implications for her policies of trends in the number of warnings from drugs companies on impending supply problems for certain products; and what steps her Department is taking to help ensure...
To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential implications for her policies of trends in the number of warnings from drugs companies on impending supply problems for certain products; and what steps her Department is taking to help ensure...
There are approximately 14,000 medicines licensed for supply in the United Kingdom, and the overwhelming majority are in good supply. The medicine supply chain is complex, global, and highly regulated, and supply issues can be caused by a range of factors. For example, suppliers can encounter manufacturing problems, difficulty accessing raw materials, and surges in demand. These are commonly cited as the drivers of recent supply issues, which have affected many countries, not just the UK.
The number of supply issue notifications received by the Department has remained relatively stable through 2022 and 2023. This followed an initial increase in 2021 following the introduction of a new reporting portal for manufacturers, in October 2020, which is used to notify the Department of potential issues, shortages, and discontinuations.
Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols (SSPs), and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.
To ask the Secretary of State for Health and Social Care, what information her Department holds on the availability of Creon 25000 across the UK.
To ask the Secretary of State for Health and Social Care, what information her Department holds on the availability of Creon 25000 across the UK.
We are aware of ongoing intermittent supply issues with Creon 25000 gastro-resistant capsules. These are due to manufacturing and active pharmaceutical ingredient constraints. The supplier has confirmed that stock of Creon 25000 gastro resistant capsules is now available, with further deliveries scheduled in May 2024. The Department has issued guidance to healthcare professionals regarding treatment of patients, while there was disruption to the supply of Creon 25000 gastro-resistant capsules. We continue to explore all management options to manage this issue. We have asked the supplier to continue confirming their future forecasts, and to inform us of any further gaps in supply of Creon 25000 gastro-resistant capsules.
Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with the suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols (SSPs), and issuing NHS communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to (a) mitigate potential future shortages of (i) Creon 25000 and (ii) other essential medicines and (b) ensure that people affected by medicine shortages have access to alternative options.
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to (a) mitigate potential future shortages of (i) Creon 25000 and (ii) other essential medicines and (b) ensure that people affected by medicine shortages have access to alternative options.
We are aware of ongoing intermittent supply issues with Creon 25000 gastro-resistant capsules. These are due to manufacturing and active pharmaceutical ingredient constraints. The supplier has confirmed that stock of Creon 25000 gastro resistant capsules is now available, with further deliveries scheduled in May 2024. The Department has issued guidance to healthcare professionals regarding treatment of patients, while there was disruption to the supply of Creon 25000 gastro-resistant capsules. We continue to explore all management options to manage this issue. We have asked the supplier to continue confirming their future forecasts, and to inform us of any further gaps in supply of Creon 25000 gastro-resistant capsules.
Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with the suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols (SSPs), and issuing NHS communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.
To ask the Secretary of State for Work and Pensions, what proportion of Universal Credit payments to couples with children are paid into the main caregiver’s account.
To ask the Secretary of State for Work and Pensions, what proportion of Universal Credit payments to couples with children are paid into the main caregiver’s account.
The requested information is not readily available and to provide it would incur disproportionate cost.
To ask the Secretary of State for Work and Pensions, how many requests for split payments of Universal Credit his Department (a) received and (b) granted in each year from 2016.
To ask the Secretary of State for Work and Pensions, how many requests for split payments of Universal Credit his Department (a) received and (b) granted in each year from 2016.
The information requested is not readily available and to provide it would incur disproportionate cost.
To ask the Secretary of State for Work and Pensions, pursuant to the Answer of 15 April 2024 to Question 20383 on State Retirement Pensions: Women, whether his Department received the Parliamentary and Health Service Ombudsman's provisional views on injustice and remedy experienced due to maladministration in communication about the...
To ask the Secretary of State for Work and Pensions, pursuant to the Answer of 15 April 2024 to Question 20383 on State Retirement Pensions: Women, whether his Department received the Parliamentary and Health Service Ombudsman's provisional views on injustice and remedy experienced due to maladministration in communication about the...
DWP received the PHSO’s provisional views for comment in November 2023.
To ask the Secretary of State for Work and Pensions, what the most common reasons cited on split payment applications are; and what assessment his Department has made of the (a) suitability and (b) effectiveness of the application process in the light of those reasons.
To ask the Secretary of State for Work and Pensions, what the most common reasons cited on split payment applications are; and what assessment his Department has made of the (a) suitability and (b) effectiveness of the application process in the light of those reasons.
The Department does not collect the information requested.
To ask the Secretary of State for Work and Pensions, whether his Department has undertaken any (a) research and (b) planning for a potential compensation scheme following the publication of the Parliamentary and Health Service Ombudsman's provisional views on injustice and remedy experienced due to maladministration in communication about the...
To ask the Secretary of State for Work and Pensions, whether his Department has undertaken any (a) research and (b) planning for a potential compensation scheme following the publication of the Parliamentary and Health Service Ombudsman's provisional views on injustice and remedy experienced due to maladministration in communication about the...
The Ombudsman did not publish his provisional views in November 2023 or at any other time. The Ombudsman published his final views on 21st March 2024.
To ask the Secretary of State for Work and Pensions, if he will publish his Department's assessment of the Parliamentary and Health Service Ombudsman's provisional views on injustice and remedy experienced due to maladministration in communication about the 1995 Pensions Act which were set out in the report published in...
To ask the Secretary of State for Work and Pensions, if he will publish his Department's assessment of the Parliamentary and Health Service Ombudsman's provisional views on injustice and remedy experienced due to maladministration in communication about the 1995 Pensions Act which were set out in the report published in...
The Ombudsman did not publish his provisional views in November 2023 or at any other time. The Ombudsman published his final views on 21st March 2024.
To ask the Secretary of State for Work and Pensions, if he will publish his Department's (a) communications and (b) minutes relating to the Parliamentary and Health Service Ombudsman's provisional views on injustice and remedy experienced due to maladministration in communication about the 1995 Pensions Act which were set out...
To ask the Secretary of State for Work and Pensions, if he will publish his Department's (a) communications and (b) minutes relating to the Parliamentary and Health Service Ombudsman's provisional views on injustice and remedy experienced due to maladministration in communication about the 1995 Pensions Act which were set out...
The Ombudsman did not publish his provisional views in November 2023 or at any other time. The Ombudsman published his final views on 21st March 2024.
To ask the Minister of State, Foreign, Commonwealth and Development Office, what assessment his Department has made of the potential risks of (a) existing and (b) enhanced (i) security, (ii) defence, (iii) science and (iv) technology relationships with Israel under the 2030 roadmap.
To ask the Minister of State, Foreign, Commonwealth and Development Office, what assessment his Department has made of the potential risks of (a) existing and (b) enhanced (i) security, (ii) defence, (iii) science and (iv) technology relationships with Israel under the 2030 roadmap.
We enjoy a close strategic partnership with Israel on a wide range of issues. The Memorandum of Understanding we signed in 2021 demonstrated our intent to deepen and expand cooperation across our mutual priorities for our mutual benefit. The subsequent 2030 roadmap outlines how this strategic partnership will continue to serve our collective interests, deepening UK-Israel cooperation across the breadth of our relationship, including science and tech, research and development and security, health, climate and gender.
To ask the Secretary of State for Business and Trade, what assessment her Department has made of the potential impact on smallholder farmers of the measures in the Intellectual Property Chapter of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership relating to the requirement for signatory countries to ratify the...
To ask the Secretary of State for Business and Trade, what assessment her Department has made of the potential impact on smallholder farmers of the measures in the Intellectual Property Chapter of the Comprehensive and Progressive Agreement for Trans-Pacific Partnership relating to the requirement for signatory countries to ratify the...
The UK’s accession to CPTPP will not change the UK’s existing commitments under the International Union for the Protection of New Varieties of Plants (UPOV).
The Government does not foresee any impacts on UK small farmers due to the UK’s legal obligations under CPTPP Article 18.7.2 because there will be no changes to the UK’s existing legislative framework in this area.
UPOV provides for plant breeders’ rights, aiming to encourage the development of new varieties of plants, with benefits such as food security and mitigating climate change.
Mechanisms are available within CPTPP to discuss issues raised by signatory countries.
To ask the Secretary of State for Business and Trade, what assessment her Department has made of the legality of imports from illegal Israeli settlements.
To ask the Secretary of State for Business and Trade, what assessment her Department has made of the legality of imports from illegal Israeli settlements.
The UK’s position on settlements is clear: they are illegal under international law and undermine the prospect of a two-state solution.
Under the existing UK-Israel trade agreement, goods originating from illegal Israeli settlements are not entitled to tariff and trade preferences under either the agreement between the UK and Israel, or the agreement between the UK and the Palestinian Liberation Organization.
I can confirm that this will not change in the upgraded FTA with Israel. The UK will not compromise on any of our longstanding positions on the Middle East Peace Process throughout this negotiation, including with respect to settlements.
To ask the Secretary of State for Business and Trade, if she will have discussions with the Leader of the House on allocating time for debate on a substantive motion relating to the UK's accession to the Comprehensive and Progressive Agreement for Trans-Pacific Partnership ahead of the conclusion of the...
To ask the Secretary of State for Business and Trade, if she will have discussions with the Leader of the House on allocating time for debate on a substantive motion relating to the UK's accession to the Comprehensive and Progressive Agreement for Trans-Pacific Partnership ahead of the conclusion of the...
The Government is committed to effective scrutiny of its trade agenda and has put in place a comprehensive framework for scrutiny of free trade agreements (FTAs). This includes a commitment to seek to hold a general debate on a new FTA where one is requested by the relevant Select Committee, subject to parliamentary time being available.
The scheduling of parliamentary business is not a matter for the Department for Business and Trade.